Laura Sutcliffe
Stock Analyst at UBS
(1.64)
# 3,013
Out of 4,820 analysts
6
Total ratings
66.67%
Success rate
-0.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Sutcliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Maintains: Buy | $290 → $285 | $234.29 | +21.64% | 1 | Apr 24, 2025 | |
| TLX Telix Pharmaceuticals | Maintains: Buy | $21 → $22 | $18.92 | +16.28% | 2 | Jan 27, 2025 | |
| ARGX argenx SE | Initiates: Buy | $390 | $615.00 | -36.59% | 1 | Jun 18, 2021 | |
| GLPG Galapagos NV | Downgrades: Neutral | n/a | $26.87 | - | 2 | Dec 20, 2019 |
ResMed
Apr 24, 2025
Maintains: Buy
Price Target: $290 → $285
Current: $234.29
Upside: +21.64%
Telix Pharmaceuticals
Jan 27, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $18.92
Upside: +16.28%
argenx SE
Jun 18, 2021
Initiates: Buy
Price Target: $390
Current: $615.00
Upside: -36.59%
Galapagos NV
Dec 20, 2019
Downgrades: Neutral
Price Target: n/a
Current: $26.87
Upside: -